MADISON ZIEGLER: Open Payments
NPI 1457075822 · CORALVILLE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$901 in 51 payments from 14 companies in 2025. Trend: 2023 $417 · 2024 $508 · 2025 $901
Food & beverage: $901
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $203 |
| ABBVIE INC. | 9 | $159 |
| Regeneron Healthcare Solutions, Inc. | 5 | $107 |
| Galderma Laboratories, L.P. | 4 | $77 |
| UCB, Inc. | 3 | $61 |
| Novartis Pharmaceuticals Corporation | 2 | $56 |
| Organon LLC | 3 | $53 |
| Arcutis Biotherapeutics, Inc. | 3 | $50 |
| Lilly USA, LLC | 3 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
Products named: TREMFYA, SKYRIZI, NEMLUVIO, DUPIXENT, Bimzelx, Zoryve, LIBTAYO, COSENTYX.
Industry payments across IA — which companies pay providers there.
